<DOC>
	<DOCNO>NCT01283659</DOCNO>
	<brief_summary>Background : The prevalence heart failure ( HF ) rapidly rise industrialize developing country . Though invasive coronary angiography ( ICA ) remain gold standard anatomical assessment coronary artery luminal stenosis patient , alternative seek . Computed tomographic coronary angiography ( CTA ) emerge accurate non-invasive diagnostic tool CAD demonstrate prognostic value . Whether CTA use patient HF diagnosis guide patient investigation management unknown . Acknowledging age population industrialize county , increase burden healthcare grow prevalence HF , need identify non-invasive diagnostic test cost-effective , readily available , safe sufficient accuracy risk stratify patient guide investigation management . Methods : The propose randomized control trial ( RCT ) evaluate clinical utility compute tomographic coronary angiography ( CTA ) investigate potential benefit resource utilization health economics patient progressive newly diagnose heart failure ( HF ) unknown etiology ( i.e . ischemic versus non- ischemic ) definition coronary anatomy require diagnosis management . The experimental algorithm compare invasive coronary angiography ( ICA ) Analysis composite clinical event major adverse cardiac event perform determine impact strategy upon patient outcome . Accuracy CTA detection coronary anatomy obstruction assess patient undergo ICA . It expect CTA cost-effective strategy diagnosis ; yield similar outcome few procedural risk improve resource utilization .</brief_summary>
	<brief_title>IMAGE-HF Project I-C : Computed Tomographic Coronary Angiography Heart Failure Patients</brief_title>
	<detailed_description>Hypotheses Primary Hypothesis : Compared ICA , diagnostic strategy algorithm use CTA patient HF unknown etiology definition coronary anatomy require diagnosis management , result reduction downstream resource utilization per patient cost . Secondary Hypotheses : I ) Compared standard care , strategy use CTA achieve : ) similar composite clinical event ( CCE ) , quality life ( QoL ) , major adverse cardiac event ( MACE ) ; b ) low rate procedure relate complication ( death , MI , stroke , vascular complication , severe allergic reaction ; contrast nephropathy ) ; c ) low rate normal ICA . II ) Using patient-based analysis vessel-based analysis , CTA good agreement ICA among patient HF CTA arm proceed ICA . Objectives The primary objective understand role CTA patient HF unknown etiology . We propose prospective randomize study 250 patient examine potential impact CTA compare ICAon resource utilization health care cost patient HF unknown CAD status . Secondary objective : compare CCE , QoL MACE CTA ICA arm . Radiation exposure safety group also assess . Trial design The propose trial multicentre randomize control trial 250 patient . In addition , retrospective review current CTA ICA databases University Ottawa Heart Institute conduct identify additional cohort patient ( 200-400 ) image modality decision already make . These patient eligible randomization , enter registry . Trial intervention - Randomization All HF patient require investigation determine etiology HF ( ischemic versus non-ischemic ) screen study . Patients randomized investigation arm CTA ICA . Patients stratify accord recruitment site pre-test probability obstructive CAD . A stratified block ( vary size ) randomization scheme use . Within stratum , patient randomize vary block size two study group . A central randomization scheme ( envelope ) , ensure concealment , use local research co-ordinator perform patient assignment . The randomization scheme generate statistician use SAS macro .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Inclusion Criteria Eligible HF patient admission hospital emergency room heart failure OR document history leave ventricular dysfunction ( LVEF &lt; 50 % ) OR document history Class lllV heart failure symptom , precede 12 month prior enrollment , diagnosis CAD uncertain definition coronary anatomy require diagnosis management . Exclusion criterion : 1 . Age &lt; 18 year lack consent , 2 . Renal Insufficiency ( GFR &lt; 45 ml/min ) ; 3 . Allergy intravenous contrast agent ; 4 . Contraindication radiation exposure ( e.g . pregnancy ) ; 5 . Uncontrolled HR time scan ( per local clinical routine ) 6 . History revascularization ( CABG PCI ) ; 7 . Atrial fibrillation , frequent atrial ventricular ectopy ( &gt; 1 / minute ) ; 8 . Unable perform 20 second breathhold ; 9 . CTA ICA within precede 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>compute tomographic angiography</keyword>
	<keyword>coronary angiogram</keyword>
	<keyword>cost effectiveness</keyword>
	<keyword>QoL</keyword>
	<keyword>Heart failure</keyword>
	<keyword>diagnostic accuracy</keyword>
	<keyword>prospective comparative effectiveness randomize clinical trial</keyword>
</DOC>